Compounds > tyrosine

tyrosine and cabozantinib

tyrosine has been researched along with cabozantinib in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Arrowsmith, E; Bauer, TM; Choueiri, TK; D'Souza, A; Figlin, R; Heath, EI; McDermott, DF; Merchan, J; Michaelson, MD; Perini, R; Roy, A; Tykodi, SS; Vickery, D; Zhao, S1
Arranz Arija, JÁ; Gallardo Díaz, E; González-Del-Alba, A; Lainez-Milagro, N; Lambea Sorrosal, J; Lázaro Quintela, M; Méndez-Vidal, MJ; Peláez Fernández, I; Perez-Valderrama, B; Suárez Rodriguez, C1

Trials

1 trial(s) available for tyrosine and cabozantinib

ArticleYear
Belzutifan plus cabozantinib for patients with advanced clear cell renal cell carcinoma previously treated with immunotherapy: an open-label, single-arm, phase 2 study.
    The Lancet. Oncology, 2023, Volume: 24, Issue:5

    Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Female; Humans; Immunotherapy; Male; Middle Aged; Protein Kinase Inhibitors; Tyrosine

2023

Other Studies

1 other study(ies) available for tyrosine and cabozantinib

ArticleYear
SEOM SOGUG clinical guideline for treatment of kidney cancer (2022).
    Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2023, Volume: 25, Issue:9

    Topics: Carcinoma, Renal Cell; Female; Humans; Kidney Neoplasms; Male; Nivolumab; Quality of Life; Sunitinib; Tyrosine

2023